Arena Pharmaceuticals Inc. (ARNA) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Arena Pharmaceuticals Inc...

    NASDAQ: ARNA · Real-Time Price · USD
    99.99
    0.00 (0.00%)
    At close: Apr 24, 2025, 3:47 PM

    Arena Pharmaceuticals Cash Flow Statement

    Financials in USD. Fiscal year is undefined.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2021
    Period Ending Dec 31, 2021
    Net Income
    		 -616.43M
    Depreciation & Amortization
    		 3.87M
    Stock-Based Compensation
    		 70.37M
    Other Working Capital
    		 16.46M
    Other Non-Cash Items
    		 66.99M
    Deferred Income Tax
    		 n/a
    Change in Working Capital
    		 23.18M
    Operating Cash Flow
    		 -452.02M
    Capital Expenditures
    		 -70.99M
    Cash Acquisitions
    		 n/a
    Purchase of Investments
    		 -612.22M
    Sales Maturities Of Investments
    		 1B
    Other Investing Acitivies
    		 n/a
    Investing Cash Flow
    		 321.4M
    Debt Repayment
    		 n/a
    Common Stock Repurchased
    		 n/a
    Dividend Paid
    		 n/a
    Other Financial Acitivies
    		 135.41M
    Financial Cash Flow
    		 135.41M
    Net Cash Flow
    		 5.03M
    Free Cash Flow
    		 -523M

    Add to Watchlist